CTOs on the Move

Franklin and Seidelmann Subspecialty Radiology

www.fs-rad.com

 
Franklin and Seidelmann Subspecialty Radiology LLC is a Beachwood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fs-rad.com
  • 23625 Commerce Park Ste 204
    Beachwood, OH USA 44122
  • Phone: 216.255.5701

Executives

Name Title Contact Details

Similar Companies

Cambridge Isotope Laboratories

Cambridge Isotope Laboratories is a Andover, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Total Environmental Service Technologies Inc

Total Environmental Service Technologies Inc is a Peru, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Continental Dental Laboratory

Continental Dental Laboratory is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medytox Solutions, Incorporated

Medytox Solutions, Inc. develops and delivers cutting-edge testing and reporting technology and systems, providing an affordable and superior service to medical providers. In turn, our medical provider clients are able to provide better and more cost-effective patient care. Medytox offers its clients a complete solution, with faster turnaround times and more reliable and accurate results, in a manner that is safe, secure and HIPAA-compliant in all respects. We conduct our testing on the most accurate and advanced equipment available, using proven methodologies to provide superior results, while supporting our clients with personnel, equipment and turn-key services dedicated to providing them with the latitude to offer an optimized level of enhanced patient care.

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome`s natural roles in promoting health.